Exploration of the mechanisms responsible for breakdown and repair of artic
ular cartilage in osteoarthritis has promoted interest in the potential use
of cartilage-derived molecules as markers of cartilage metabolism in this
disease. Many of the macromolecules detectable in synovial fluid have been
evaluated as possible surrogate markers of the severity or activity of dise
ase processes. Measurements of the synovial fluid concentration of any mark
er without due consideration of the fate of the molecule in the joint cavit
y are likely to be misleading and insufficient to cement a relationship bet
ween marker concentration and the severity of articular pathology.